A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens
about
Recent developments in clinical trial designs for HIV vaccine researchModeling HIV vaccine trials of the future.Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacySurrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice Definition.HIV Vaccine Trials Network: activities and achievements of the first decade and beyond.In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalitiesNew clinical trial designs for HIV vaccine evaluation.Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design.Lessons learned from HIV vaccine clinical efficacy trials.Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.Design and estimation for evaluating principal surrogate markers in vaccine trials.Statistical methods for down-selection of treatment regimens based on multiple endpoints, with application to HIV vaccine trials.Power/sample size calculations for assessing correlates of risk in clinical efficacy trials.Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.
P2860
Q28083514-65FF1C13-F2FB-483D-B2B2-CC544076DAEFQ30393307-C605AECE-8B3A-4FE7-9DB6-A47801CFFA9AQ30714941-387575AF-5C11-46B4-A91A-9377D380B4E4Q36407392-BAD0607F-C4AE-44F0-9BE8-4DA2D8468D4EQ36464748-2A234603-3A33-4BEF-9078-A6C95C32956AQ37258303-BEFCF9EA-8A21-4D61-A7C6-F683C5D827F5Q37412300-F4445447-7346-4D2F-93B2-E45C01BCA405Q37615969-6B21C8CE-2E30-4D4F-8AEE-AF0CF46B7E46Q37724091-0E2E3EBE-DD37-4459-8D39-EF80ED1B0FAEQ38716886-C83735BE-23AE-4FA1-BC89-A3C41C061A20Q39467318-692A86D0-2988-4B8E-A481-4DB1DFDB63D2Q40533695-05F28F74-4677-467E-8F08-D2F6FFE6A45AQ40731419-59869E57-4123-4C7A-9BFE-C9BF767E2CB1Q46296261-487DE995-00BC-4350-AEB5-EA3637D9924A
P2860
A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
A Sequential Phase 2b Trial De ...... Multiple HIV Vaccine Regimens
@ast
A Sequential Phase 2b Trial De ...... Multiple HIV Vaccine Regimens
@en
type
label
A Sequential Phase 2b Trial De ...... Multiple HIV Vaccine Regimens
@ast
A Sequential Phase 2b Trial De ...... Multiple HIV Vaccine Regimens
@en
prefLabel
A Sequential Phase 2b Trial De ...... Multiple HIV Vaccine Regimens
@ast
A Sequential Phase 2b Trial De ...... Multiple HIV Vaccine Regimens
@en
P2093
P2860
P356
P1476
A Sequential Phase 2b Trial De ...... Multiple HIV Vaccine Regimens
@en
P2093
Douglas Grove
Glenda Gray
James Kublin
Lawrence Corey
Peter B Gilbert
Scott M Hammer
Steven G Self
Susan P Buchbinder
Ying Huang
P2860
P356
10.2202/1948-4690.1037
P50
P577
2011-10-01T00:00:00Z